Use of Remdesivir in Patients Hospitalized for COVID-19 Pneumonia: Effect on the Hypoxic and Inflammatory State

Remdesivir is one of the most attractive options for patients with hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19). The aim of our study was to evaluate the effect of remdesivir on the hypoxic and inflammatory state in patients with moderate to severe COVID-19. We retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Libra, Alessandro, Ciancio, Nicola, Sambataro, Gianluca, Sciacca, Enrico, Muscato, Giuseppe, Marino, Andrea, Vancheri, Carlo, Spicuzza, Lucia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612076/
https://www.ncbi.nlm.nih.gov/pubmed/37896877
http://dx.doi.org/10.3390/v15102101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10612076/
https://www.ncbi.nlm.nih.gov/pubmed/37896877
http://dx.doi.org/10.3390/v15102101

Ejemplares similares